Saudi Arabia Dialysis Market by Dialysis Type (Hemodialysis and Peritoneal Dialysis), Products & Services (Equipment, Consumables, Drugs, and Services), End User (In-center Dialysis, and Home Dialysis) – Opportunity Analysis and Industry Forecast, 2024–2030

Saudi Arabia Dialysis Market

Industry:  Life Sciences & Healthcare | Publish Date: Feb 2024 | No of Pages:  101 | No. Tables:  71 | No. Figures:  36

Market Overview:

The Saudi Arabia Dialysis Market size was valued at USD 0.14 billion in 2023, and is expected to reach USD 0.19 billion by 2030, with a CAGR of 4.4% from 2024 to 2030.

Dialysis is a life-sustaining medical procedure used to manage patients with end-stage renal disease (ESRD) or acute kidney injuries. This market includes various products and services such as hemodialysis and peritoneal dialysis equipment, dialysis consumables, and associated pharmaceuticals. Given the growing prevalence of kidney-related disorders and the increasing aging population, the market is crucial in delivering essential renal care, aiming to enhance patients' quality of life and improve overall healthcare outcomes.

Growth in Chronic Kidney Disease (CKD) is a Driving Force Behind the Expansion of the Dialysis Market

The rising incidence of Chronic Kidney Disease (CKD) is a principal catalyst propelling the expansion of the dialysis market. The rising prevalence of predisposing conditions such as diabetes and hypertension, has significantly contributed to the surge in CKD cases worldwide.

As these risk factors become more pervasive in contemporary lifestyles, a larger segment of the population is predisposed to kidney dysfunction, necessitating the need for renal replacement therapies that include dialysis. Delayed diagnosis and the increasing burden of non-communicable diseases, coupled with lifestyle-related contributors to CKD, have collectively elevated the number of individuals requiring immediate intervention through dialysis.

Improved diagnostic capabilities and heightened patient awareness have also played pivotal roles in the early identification of CKD cases, prompting timely therapeutic measures, including the widespread adoption of dialysis. In this landscape, the dialysis market emerges as an indispensable cornerstone in addressing the mounting healthcare challenges posed by the growing incidence of CKD.

 

Technological Advancements in Dialysis Machines is Driving the Market to Grow:

Continuous innovation in dialysis machine technology is a significant driver for the Saudi Arabia dialysis market. Modern dialysis machines are equipped with advanced features, including improved filtration mechanisms, enhanced portability, and user-friendly interfaces.

These technological advancements not only enhance the overall efficiency of dialysis treatments but also contribute to a more comfortable and convenient experience for both healthcare providers and patients. As these machines evolve, they offer better precision in removing toxins from the blood, leading to improved outcomes and patient satisfaction.

The integration of smart technologies and connectivity features further facilitates remote monitoring and data management, streamlining the overall dialysis process and supporting personalized treatment plans. The continuous pursuit of technological excellence in dialysis machines positions them as essential tools in the management of kidney-related disorders, driving the growth of the dialysis market.

Limited awareness among individuals restraint the market growth

The limited awareness among the general population regarding kidney diseases is a significant impediment to the growth of the dialysis market. Insufficient knowledge about the early signs, risk factors, and preventive measures related to chronic kidney disease (CKD) contributes to delayed diagnoses and a lack of proactive healthcare-seeking behavior.

Without a widespread understanding of the importance of regular kidney screenings and the potential efficacy of dialysis in managing renal conditions, individuals may overlook or underestimate the severity of their kidney health. This lack of awareness not only results in delayed initiation of dialysis treatment but also hampers the overall demand for dialysis services.

Bridging this awareness gap through targeted education campaigns and community outreach initiatives is imperative to enhance early detection, encourage timely intervention, and ultimately drive the growth of the dialysis market by ensuring that individuals are well-informed about the available treatment options for kidney-related disorders.

 

The Introduction of Wearable and Portable Dialysis Devices Creates Future Opportunity for the Market

The emergence of wearable and portable dialysis devices stands as a groundbreaking advancement in dialysis technology, offering a transformative opportunity for the dialysis market. These compact systems, resembling small backpacks, empower patients with unprecedented mobility and flexibility in their treatment schedules.

For instance, AWAK Technologies (AWAK), an innovative medical technology firm specializing in dialysis using regenerative technology for end-stage renal disease, revealed that the U.S. Food and Drug Administration (FDA) conferred the breakthrough device designation upon its AWAK Peritoneal Dialysis (AWAK PD) device.

This device, which is both wearable and highly portable, incorporates AWAK's patented sorbent technology. As technology continues to advance, we can anticipate further innovations in dialysis technology, ultimately leading to even better outcomes for patients.

 

Competitive Landscape

Several market players operating in the Saudi Arabia dialysis market include Baxter International, Inc., DaVita Inc., Nikkiso Co. Ltd., NxStage Medical, Inc., Asahi Kasei Corporation, Medicators, Inc, Fresenius Medical Care AG & Co. KGaA, Nipro Corporation, B. Braun Avitum AG, Diaverum Deutschland GmbH, and others.

Saudi Arabia Dialysis Market Key Segments

By Dialysis Type

  • Hemo Dialysis

  • Peritoneal Dialysis

By Products & Services

  • Equipment

  • Consumables

  • Drugs

  • Services

By End User

  • In-center Dialysis

  • Home Dialysis

REPORT SCOPE AND SEGMENTATION:

Parameters

Details

Market Size in 2023

USD 0.14 Billion

Revenue Forecast in 2030

USD 0.19 Billion

Growth Rate

CAGR of 4.4% from 2024 to 2030

Analysis Period

2023–2030

Base Year Considered

2023

Forecast Period

2024–2030

Market Size Estimation

Billion (USD)

Growth Factors

  • Technological Advancements in Dialysis Machines

  • Growth in Chronic Kidney Disease (CKD)

Companies Profiled

10

Market Share

Available for 10 companies

Customization Scope

Free customization (equivalent up to 80 working hours of analysts) after purchase. Addition or alteration to country, regional, and segment scope.

Pricing and Purchase Options

Avail customized purchase options to meet your exact research needs.

Test

1      INTRODUCTION

           1.1      REPORT DESCRIPTION

           1.2      RESEARCH METHODOLOGY

                         1.2.1      SECONDARY RESEARCH

                         1.2.2      DATA ANALYSIS FRAMEWORK

                         1.2.3      MARKET SIZE ESTIMATION

                         1.2.4      FORECASTING

                         1.2.5      PRIMARY RESEARCH AND DATA VALIDATION

2      SAUDI ARABIA DIALYSIS MARKET – EXECUTIVE SUMMARY

           2.1.      MARKET SNAPSHOT, 2023 - 2030, MILLION USD

3      PORTER’S FIVE FORCE MODEL ANALYSIS

           3.1      BARGAINING POWER OF SUPPLIERS

           3.2      BARGAINING POWER OF BUYERS

           3.3      DEGREE OF COMPETITION

           3.4      THREAT OF SUBSTITUTE

           3.5      THREAT OF NEW ENTRANTS

4      MARKET SHARE ANALYSIS

           4.1      MARKET SHARE ANALYSIS OF TOP PROVIDERS, 2023

5      MARKET DYNAMICS

           5.1      GROWTH DRIVERS

                         5.1.1      DRIVER 1

                         5.1.2      DRIVER 2

                         5.1.3      DRIVER 3

                         5.1.4      DRIVER 4

           5.2      CHALLENGES

                         5.2.1      CHALLENGE 1

                         5.2.2      CHALLENGE 2

                         5.2.3      CHALLENGE 3

                         5.2.4      CHALLENGE 4

           5.3      OPPORTUNITIES

                         5.3.1      OPPORTUNITY 1

                         5.3.2      OPPORTUNITY 2

6       SAUDI ARABIA DIALYSIS MARKET BY DIALYSIS TYPE

           6.1      OVERVIEW

           6.2      HEMO DIALYSIS MARKET

           6.3      PERITONEAL DIALYSIS MARKET

7       SAUDI ARABIA DIALYSIS MARKET BY PRODUCTS AND SERVICES

           7.1      OVERVIEW

           7.2      EQUIPMENT MARKET

           7.3      CONSUMABLES MARKET

           7.4      DRUGS MARKET

           7.5      SERVICES MARKET

8       SAUDI ARABIA DIALYSIS MARKET BY END USER

           8.1      OVERVIEW

           8.2      IN-CENTER DIALYSIS MARKET

           8.3      HOME DIALYSIS MARKET

9     COMPANY PROFILES

           9.1     BAXTER INTERNATIONAL INC.

                         9.1.1     COMPANY OVERVIEW

                         9.1.2     COMPANY SNAPSHOT

                         9.1.3     OPERATING BUSINESS SEGMENTS

                         9.1.4     PRODUCT PORTFOLIO

                         9.1.5     BUSINESS PERFORMANCE

                         9.1.6     BUSINESS SEGMENTS

                         9.1.7     GEOGRAPHIC SEGMENTS

                         9.1.8     KEY STRATEGIC MOVES AND DEVELOPMENT

                         9.1.9     PRIMARY MARKET COMPETITORS

           9.2     DAVITA INC.

                         9.2.1     COMPANY OVERVIEW

                         9.2.2     COMPANY SNAPSHOT

                         9.2.3     OPERATING BUSINESS SEGMENTS

                         9.2.4     PRODUCT PORTFOLIO

                         9.2.5     BUSINESS PERFORMANCE

                         9.2.6     BUSINESS SEGMENTS

                         9.2.7     GEOGRAPHIC SEGMENTS

                         9.2.8     KEY STRATEGIC MOVES AND DEVELOPMENT

                         9.2.9     PRIMARY MARKET COMPETITORS

           9.3     NIKKISO CO. LTD.

                         9.3.1     COMPANY OVERVIEW

                         9.3.2     COMPANY SNAPSHOT

                         9.3.3     OPERATING BUSINESS SEGMENTS

                         9.3.4     PRODUCT PORTFOLIO

                         9.3.5     BUSINESS PERFORMANCE

                         9.3.6     BUSINESS SEGMENTS

                         9.3.7     GEOGRAPHIC SEGMENTS

                         9.3.8     KEY STRATEGIC MOVES AND DEVELOPMENT

                         9.3.9     PRIMARY MARKET COMPETITORS

           9.4     NXSTAGE MEDICAL, INC.

                         9.4.1     COMPANY OVERVIEW

                         9.4.2     COMPANY SNAPSHOT

                         9.4.3     OPERATING BUSINESS SEGMENTS

                         9.4.4     PRODUCT PORTFOLIO

                         9.4.5     BUSINESS PERFORMANCE

                         9.4.6     BUSINESS SEGMENTS

                         9.4.7     GEOGRAPHIC SEGMENTS

                         9.4.8     KEY STRATEGIC MOVES AND DEVELOPMENT

                         9.4.9     PRIMARY MARKET COMPETITORS

           9.5     ASAHI KASEI CORPORATION

                         9.5.1     COMPANY OVERVIEW

                         9.5.2     COMPANY SNAPSHOT

                         9.5.3     OPERATING BUSINESS SEGMENTS

                         9.5.4     PRODUCT PORTFOLIO

                         9.5.5     BUSINESS PERFORMANCE

                         9.5.6     BUSINESS SEGMENTS

                         9.5.7     GEOGRAPHIC SEGMENTS

                         9.5.8     KEY STRATEGIC MOVES AND DEVELOPMENT

                         9.5.9     PRIMARY MARKET COMPETITORS

           9.6     MEDICATORS, INC.

                         9.6.1     COMPANY OVERVIEW

                         9.6.2     COMPANY SNAPSHOT

                         9.6.3     OPERATING BUSINESS SEGMENTS

                         9.6.4     PRODUCT PORTFOLIO

                         9.6.5     BUSINESS PERFORMANCE

                         9.6.6     BUSINESS SEGMENTS

                         9.6.7     GEOGRAPHIC SEGMENTS

                         9.6.8     KEY STRATEGIC MOVES AND DEVELOPMENT

                         9.6.9     PRIMARY MARKET COMPETITORS

           9.7     FRESENIUS MEDICAL CARE AG AND CO. KGAA

                         9.7.1     COMPANY OVERVIEW

                         9.7.2     COMPANY SNAPSHOT

                         9.7.3     OPERATING BUSINESS SEGMENTS

                         9.7.4     PRODUCT PORTFOLIO

                         9.7.5     BUSINESS PERFORMANCE

                         9.7.6     BUSINESS SEGMENTS

                         9.7.7     GEOGRAPHIC SEGMENTS

                         9.7.8     KEY STRATEGIC MOVES AND DEVELOPMENT

                         9.7.9     PRIMARY MARKET COMPETITORS

           9.8     NIPRO CORPORATION

                         9.8.1     COMPANY OVERVIEW

                         9.8.2     COMPANY SNAPSHOT

                         9.8.3     OPERATING BUSINESS SEGMENTS

                         9.8.4     PRODUCT PORTFOLIO

                         9.8.5     BUSINESS PERFORMANCE

                         9.8.6     BUSINESS SEGMENTS

                         9.8.7     GEOGRAPHIC SEGMENTS

                         9.8.8     KEY STRATEGIC MOVES AND DEVELOPMENT

                         9.8.9     PRIMARY MARKET COMPETITORS

           9.9     B. BRAUN AVITUM AG

                         9.9.1     COMPANY OVERVIEW

                         9.9.2     COMPANY SNAPSHOT

                         9.9.3     OPERATING BUSINESS SEGMENTS

                         9.9.4     PRODUCT PORTFOLIO

                         9.9.5     BUSINESS PERFORMANCE

                         9.9.6     BUSINESS SEGMENTS

                         9.9.7     GEOGRAPHIC SEGMENTS

                         9.9.8     KEY STRATEGIC MOVES AND DEVELOPMENT

                         9.9.9     PRIMARY MARKET COMPETITORS

           9.10     DIAVERUM DEUTSCHLAND GMBH

                         9.10.1     COMPANY OVERVIEW

                         9.10.2     COMPANY SNAPSHOT

                         9.10.3     OPERATING BUSINESS SEGMENTS

                         9.10.4     PRODUCT PORTFOLIO

                         9.10.5     BUSINESS PERFORMANCE

                         9.10.6     BUSINESS SEGMENTS

                         9.10.7     GEOGRAPHIC SEGMENTS

                         9.10.8     KEY STRATEGIC MOVES AND DEVELOPMENT

                         9.10.9     PRIMARY MARKET COMPETITORS

LIST OF TABLES

TABLE 1. SAUDI ARABIA DIALYSIS MARKET VALUE, BY DIALYSIS TYPE, 2023-2030, (MILLION USD)

TABLE 2. HEMO DIALYSIS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 3. PERITONEAL DIALYSIS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 4. SAUDI ARABIA DIALYSIS MARKET VALUE, BY PRODUCTS AND SERVICES, 2023-2030, (MILLION USD)

TABLE 5. EQUIPMENT, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 6. CONSUMABLES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 7. DRUGS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 8. SERVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 9. SAUDI ARABIA DIALYSIS MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)

TABLE 10. IN-CENTER DIALYSIS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 11. HOME DIALYSIS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 12. BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT

TABLE 13. BAXTER INTERNATIONAL INC.: OPERATING BUSINESS SEGMENTS

TABLE 14. BAXTER INTERNATIONAL INC.: PRODUCT PORTFOLIO

TABLE 15. BAXTER INTERNATIONAL INC.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 16. BAXTER INTERNATIONAL INC.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 17. BAXTER INTERNATIONAL INC.: KEY STRATERGY

TABLE 18. DAVITA INC.: COMPANY SNAPSHOT

TABLE 19. DAVITA INC.: OPERATING BUSINESS SEGMENTS

TABLE 20. DAVITA INC.: PRODUCT PORTFOLIO

TABLE 21. DAVITA INC.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 22. DAVITA INC.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 23. DAVITA INC.: KEY STRATERGY

TABLE 24. NIKKISO CO. LTD.: COMPANY SNAPSHOT

TABLE 25. NIKKISO CO. LTD.: OPERATING BUSINESS SEGMENTS

TABLE 26. NIKKISO CO. LTD.: PRODUCT PORTFOLIO

TABLE 27. NIKKISO CO. LTD.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 28. NIKKISO CO. LTD.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 29. NIKKISO CO. LTD.: KEY STRATERGY

TABLE 30. NXSTAGE MEDICAL, INC.: COMPANY SNAPSHOT

TABLE 31. NXSTAGE MEDICAL, INC.: OPERATING BUSINESS SEGMENTS

TABLE 32. NXSTAGE MEDICAL, INC.: PRODUCT PORTFOLIO

TABLE 33. NXSTAGE MEDICAL, INC.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 34. NXSTAGE MEDICAL, INC.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 35. NXSTAGE MEDICAL, INC.: KEY STRATERGY

TABLE 36. ASAHI KASEI CORPORATION: COMPANY SNAPSHOT

TABLE 37. ASAHI KASEI CORPORATION: OPERATING BUSINESS SEGMENTS

TABLE 38. ASAHI KASEI CORPORATION: PRODUCT PORTFOLIO

TABLE 39. ASAHI KASEI CORPORATION: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 40. ASAHI KASEI CORPORATION: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 41. ASAHI KASEI CORPORATION: KEY STRATERGY

TABLE 42. MEDICATORS, INC.: COMPANY SNAPSHOT

TABLE 43. MEDICATORS, INC.: OPERATING BUSINESS SEGMENTS

TABLE 44. MEDICATORS, INC.: PRODUCT PORTFOLIO

TABLE 45. MEDICATORS, INC.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 46. MEDICATORS, INC.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 47. MEDICATORS, INC.: KEY STRATERGY

TABLE 48. FRESENIUS MEDICAL CARE AG AND CO. KGAA: COMPANY SNAPSHOT

TABLE 49. FRESENIUS MEDICAL CARE AG AND CO. KGAA: OPERATING BUSINESS SEGMENTS

TABLE 50. FRESENIUS MEDICAL CARE AG AND CO. KGAA: PRODUCT PORTFOLIO

TABLE 51. FRESENIUS MEDICAL CARE AG AND CO. KGAA: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 52. FRESENIUS MEDICAL CARE AG AND CO. KGAA: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 53. FRESENIUS MEDICAL CARE AG AND CO. KGAA: KEY STRATERGY

TABLE 54. NIPRO CORPORATION: COMPANY SNAPSHOT

TABLE 55. NIPRO CORPORATION: OPERATING BUSINESS SEGMENTS

TABLE 56. NIPRO CORPORATION: PRODUCT PORTFOLIO

TABLE 57. NIPRO CORPORATION: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 58. NIPRO CORPORATION: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 59. NIPRO CORPORATION: KEY STRATERGY

TABLE 60. B. BRAUN AVITUM AG: COMPANY SNAPSHOT

TABLE 61. B. BRAUN AVITUM AG: OPERATING BUSINESS SEGMENTS

TABLE 62. B. BRAUN AVITUM AG: PRODUCT PORTFOLIO

TABLE 63. B. BRAUN AVITUM AG: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 64. B. BRAUN AVITUM AG: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 65. B. BRAUN AVITUM AG: KEY STRATERGY

TABLE 66. DIAVERUM DEUTSCHLAND GMBH: COMPANY SNAPSHOT

TABLE 67. DIAVERUM DEUTSCHLAND GMBH: OPERATING BUSINESS SEGMENTS

TABLE 68. DIAVERUM DEUTSCHLAND GMBH: PRODUCT PORTFOLIO

TABLE 69. DIAVERUM DEUTSCHLAND GMBH: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 70. DIAVERUM DEUTSCHLAND GMBH: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 71. DIAVERUM DEUTSCHLAND GMBH: KEY STRATERGY

LIST OF FIGURES

FIGURE 1. BARGAINING POWER OF SUPPLIERS

FIGURE 2. BARGAINING POWER OF BUYERS

FIGURE 3. DEGREE OF COMPETITION

FIGURE 4. THREAT OF SUBSTITUTE

FIGURE 5. THREAT OF NEW ENTRANTS

FIGURE 6. SAUDI ARABIA DIALYSIS MARKET VALUE, BY DIALYSIS TYPE, 2023-2030, (MILLION USD)

FIGURE 7. HEMO DIALYSIS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 8. PERITONEAL DIALYSIS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 9. SAUDI ARABIA DIALYSIS MARKET VALUE, BY PRODUCTS AND SERVICES, 2023-2030, (MILLION USD)

FIGURE 10. EQUIPMENT, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 11. CONSUMABLES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 12. DRUGS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 13. SERVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 14. SAUDI ARABIA DIALYSIS MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)

FIGURE 15. IN-CENTER DIALYSIS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 16. HOME DIALYSIS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 17. BAXTER INTERNATIONAL INC.: NET SALES, (2021-2023)

FIGURE 18. BAXTER INTERNATIONAL INC.: PRIMARY MARKET COMPETITORS

FIGURE 19. DAVITA INC.: NET SALES, (2021-2023)

FIGURE 20. DAVITA INC.: PRIMARY MARKET COMPETITORS

FIGURE 21. NIKKISO CO. LTD.: NET SALES, (2021-2023)

FIGURE 22. NIKKISO CO. LTD.: PRIMARY MARKET COMPETITORS

FIGURE 23. NXSTAGE MEDICAL, INC.: NET SALES, (2021-2023)

FIGURE 24. NXSTAGE MEDICAL, INC.: PRIMARY MARKET COMPETITORS

FIGURE 25. ASAHI KASEI CORPORATION: NET SALES, (2021-2023)

FIGURE 26. ASAHI KASEI CORPORATION: PRIMARY MARKET COMPETITORS

FIGURE 27. MEDICATORS, INC.: NET SALES, (2021-2023)

FIGURE 28. MEDICATORS, INC.: PRIMARY MARKET COMPETITORS

FIGURE 29. FRESENIUS MEDICAL CARE AG AND CO. KGAA: NET SALES, (2021-2023)

FIGURE 30. FRESENIUS MEDICAL CARE AG AND CO. KGAA: PRIMARY MARKET COMPETITORS

FIGURE 31. NIPRO CORPORATION: NET SALES, (2021-2023)

FIGURE 32. NIPRO CORPORATION: PRIMARY MARKET COMPETITORS

FIGURE 33. B. BRAUN AVITUM AG: NET SALES, (2021-2023)

FIGURE 34. B. BRAUN AVITUM AG: PRIMARY MARKET COMPETITORS

FIGURE 35. DIAVERUM DEUTSCHLAND GMBH: NET SALES, (2021-2023)

FIGURE 36. DIAVERUM DEUTSCHLAND GMBH: PRIMARY MARKET COMPETITORS

KEY PLAYERS

  • Baxter International, Inc.

  • DaVita Inc.

  • Nikkiso Co. Ltd.

  • NxStage Medical, Inc.

  • Asahi Kasei Corporation

  • Medicators, Inc.

  • Fresenius Medical Care AG & Co. KGaA

  • Nipro Corporation

  • B. Braun Avitum AG

  • Diaverum Deutschland GmbH


Frequently Asked Questions
Which are the top companies operating in the Saudi Arabia dialysis market?

The leading companies in Saudi Arabia dialysis market include Fresenius Medical Care AG & Co. KGaA, Baxter International Inc., DaVita Inc., Nipro Corporation, B. Braun Melsungen AG, and others.

What is the estimated revenue of the Saudi Arabia dialysis market by the end of 2030?

According to projections from Next Move Strategy Consulting, the Saudi Arabia dialysis market is anticipated to reach USD 0.19 billion by 2030.

What are the key challenges faced by the Saudi Arabia dialysis market?

The significant challenges in the Saudi Arabia dialysis market is inherent risk of infections and complications associated with these procedures.

What are the segmentations of Saudi Arabia dialysis market?

Saudi Arabia dialysis market is segmented on the basis of dialysis type, products and services, end-user and region.

What is the market size of the Saudi Arabia dialysis market in 2023?

The Saudi Arabia dialysis market was valued at USD 0.14 billion in 2023, as per the findings of Next Move Strategy Consulting's report.